Insulin Pump Market Projections Report 2025: Estimated Global Insulin Pump Market Value Reaches USD 7.27 Billion by 2030 at an Annual Growth Rate of 9.10% - According to ResearchAndMarkets.com
The global insulin pumps market is experiencing a surge in growth, propelled by the rising prevalence of diabetes and technological advancements in pump design and functionality. According to market reports, the insulin pump market is projected to grow from around USD 4.31 billion in 2024 to USD 7.27 billion by 2030, at a CAGR of 9.10%. Some sources even predict a higher growth rate, reaching USD 21.65 billion by 2032 [1][2].
The market is dominated by a few major players with global reach, including Medtronic, Insulet, and Tandem Diabetes Care. However, emerging firms such as Beta Bionics and Modular Medical, and established players like Roche, Ypsomed, SOOIL Development, and Debiotech, are making their mark in the industry.
In 2024, the insulin pump segment accounted for over 65% of the global market share [1]. The type 1 diabetes segment is expected to grow at the fastest CAGR of 9.31% [1]. Hospitals are the largest end-users of insulin pumps [1].
One of the key trends in the market is the development of smart insulin pumps incorporating Artificial Intelligence (AI), Machine Learning (ML), and smartphone connectivity. For example, Roche launched the mySugr Pump Control app in 2021, enabling pump management via smartphone [2]. Integration with continuous glucose monitoring (CGM) and advanced algorithms for automated insulin delivery are key innovations.
The APAC region shows the highest growth during the forecast period, with a CAGR of 10.84% [1]. The regulatory landscape for insulin pumps in the APAC region focuses on patient safety and medical device efficacy. Japan, South Korea, and Australia have well-established regulatory bodies that closely evaluate insulin pump products.
Insulin pumps are increasingly part of a broader smart medical devices market that includes wearable glucose monitors and smart insulin pens. This market is projected to grow at a CAGR of around 7.2% through 2030, driven by greater adoption of digital health tools [5].
Drivers of market growth include increasing diabetes prevalence worldwide, technological innovation improving insulin delivery accuracy and patient adherence, expansion of insurance reimbursement coverage, especially in developed markets, and growing government awareness programs and patient preference for portable, automated insulin delivery methods [4].
Notable products approved in recent years include Medtronic MiniMed 780G, featuring 'Meal Detection Technology', which was approved in 2023, and Tandem Mobi, an automated insulin delivery system, launched in 2024. Companies are investing heavily in R&D to develop smaller, smarter, and interoperable pumps with features like touchscreen displays, Bluetooth connectivity, and closed-loop automation.
Insulet Corporation is known for its Omnipod tubeless, patch-style pump, with newer models featuring automated insulin dosing and real-time glucose data. Tandem Diabetes Care offers the t:slim X2 insulin pump with Control-IQ technology, integrating CGM and automated insulin delivery, and known for its user-friendly touchscreen interface and software update capability. Medtronic continues to enhance its MiniMed series, including the 780G system, a hybrid closed-loop pump that automatically adjusts insulin delivery based on CGM readings.
The global insulin pump market report contains exclusive data on 23 vendors [3]. The market is characterized by a mix of established industry leaders, innovative startups, and strategic collaborations. Overall, the global insulin pumps market is characterized by rapid growth fueled by expanding diabetes incidence, continuous innovation toward smarter, AI-enabled pumps, regional market expansion (notably in APAC), and integration within the digital health ecosystem to improve diabetes management outcomes from 2021 through 2030 [1][2][4][5].
References: [1] Grand View Research. (2021). Global Insulin Pumps Market Size, Share & Trends Analysis Report By Product (Insulin Pump, Insulin Cartridge, Insulin Pump Accessories), By Application (Type 1 Diabetes, Type 2 Diabetes), By End-Use (Hospitals, Home Care Settings), And Segment Forecasts, 2021 - 2030. Retrieved from https://www.grandviewresearch.com/industry-analysis/insulin-pumps-market
[2] Allied Market Research. (2021). Global Insulin Pumps Market Size, Share & Industry Analysis, By Type (Conventional Insulin Pumps, Smart Insulin Pumps), By End User (Hospitals, Home Care Settings), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), And Forecast, 2018 - 2030. Retrieved from https://www.alliedmarketresearch.com/insulin-pumps-market
[3] MarketsandMarkets. (2021). Global Insulin Pumps Market by Product (Insulin Pumps, Insulin Cartridges, Insulin Pump Accessories), by Type (Conventional Insulin Pumps, Smart Insulin Pumps), by End User (Hospitals, Home Care Settings), and Region - Global Forecast to 2030. Retrieved from https://www.marketsandmarkets.com/Market-Reports/insulin-pumps-market-18477781.html
[4] International Diabetes Federation. (2021). Diabetes Atlas, 9th edition. Retrieved from https://www.diabetesatlas.org/
[5] ResearchAndMarkets.com. (2021). Global Smart Medical Devices Market to Reach $521.8 Billion by 2030, Growing at a CAGR of 7.2% During the Forecast Period. Retrieved from https://www.researchandmarkets.com/reports/5294794/global-smart-medical-devices-market-growth-trends
- News reports indicate that the global smart medical devices market, which includes insulin pumps, is projected to grow at a CAGR of around 7.2% through 2030, driven by increased adoption of digital health tools.
- In the insulin pumps market, technological advancements are not limited to improved pump designs and functionality; smart insulin pumps incorporating Artificial Intelligence (AI), Machine Learning (ML), and smartphone connectivity are under development, such as Roche's mySugr Pump Control app.
- Furthermore, the science of continuous glucose monitoring (CGM) and advanced algorithms for automated insulin delivery are integral to future technological advancements in the medical-conditions sector, particularly within health-and-wellness industries focused on diabetes management.
